Bott Rebecca C, McFee Ryann M, Clopton Debra T, Toombs Candice, Cupp Andrea S
Department of Animal Science, University of Nebraska-Lincoln, Lincoln, Nebraska 68583-0908, USA.
Biol Reprod. 2006 Jul;75(1):56-67. doi: 10.1095/biolreprod.105.047225. Epub 2006 May 3.
Morphological male sex determination is dependent on migration of endothelial and preperitubular cells from the adjacent mesonephros into the developing testis. Our hypothesis is that VEGFA and its receptor KDR are necessary for both testicular cord formation and neovascularization. The Vegfa gene has 8 exons with many splice variants. Vegfa120, Vegfa164, and Vegfa188 mRNA isoforms were detected on Embryonic Day (E) 13.5 (plug date=E0) in the rat. Vegfa120, Vegfa144, Vegfa164, Vegfa188, and Vegfa205 mRNA were detected at E18 and Postnatal Day 3 (P3). Kdr mRNA was present on E13.5, whereas Fms-like tyrosine kinase 1 receptor (Flt1) mRNA was not detected until E18. VEGFA protein was localized to Sertoli cells at cord formation and KDR to germ and interstitial cells. The VEGFA signaling inhibitors SU1498 (40 microM) and VEGFR-TKI (8 microM) inhibited cord formation in E13 testis cultures with 90% reduced vascular density (P<0.01) in VEGFR-TKI-treated organs. Furthermore, Je-11 (10 microM), an antagonist to VEGFA, also perturbed cord formation and inhibited vascular density by more than 50% (P<0.01). To determine signal transduction pathways involved in VEGFA's regulation of testis morphogenesis, E13 testis were treated with LY 294002 (15 microM), a phosphoinositide 3-kinase (PI3K) pathway inhibitor, resulting in inhibition of both vascular density (46%) and cord formation. Thus, we support our hypothesis and conclude that VEGFA, secreted by the Sertoli cell, is involved in both neovascularization and cord formation and potentially acts through the PI3K pathway during testis morphogenesis to elicit its effects.
雄性性别决定的形态学过程依赖于内皮细胞和肾小管周围前体细胞从相邻的中肾迁移至发育中的睾丸。我们的假设是,血管内皮生长因子A(VEGFA)及其受体激酶插入域受体(KDR)对于睾丸索形成和新血管生成均是必需的。Vegfa基因有8个外显子,存在许多剪接变体。在大鼠胚胎第13.5天(合笼日期=胚胎第0天)检测到Vegfa120、Vegfa164和Vegfa188 mRNA异构体。在胚胎第18天和出生后第3天(P3)检测到Vegfa120、Vegfa144、Vegfa164、Vegfa188和Vegfa205 mRNA。Kdr mRNA在胚胎第13.5天存在,而类Fms样酪氨酸激酶1受体(Flt1)mRNA直到胚胎第18天才被检测到。在睾丸索形成时,VEGFA蛋白定位于支持细胞,而KDR定位于生殖细胞和间质细胞。VEGFA信号抑制剂SU1498(40微摩尔)和VEGFR-TKI(8微摩尔)抑制胚胎第13天睾丸培养物中的睾丸索形成,在VEGFR-TKI处理的器官中血管密度降低90%(P<0.01)。此外,VEGFA拮抗剂Je-11(10微摩尔)也扰乱睾丸索形成并使血管密度降低超过50%(P<0.01)。为了确定参与VEGFA对睾丸形态发生调节的信号转导途径,用磷脂酰肌醇3激酶(PI3K)途径抑制剂LY 294002(15微摩尔)处理胚胎第13天的睾丸,导致血管密度(46%)和睾丸索形成均受到抑制。因此,我们支持我们的假设,并得出结论:支持细胞分泌的VEGFA参与新血管生成和睾丸索形成,并可能在睾丸形态发生过程中通过PI3K途径发挥作用以产生其效应。